glucagon has been researched along with Diabetic Cardiomyopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, M; Fu, CL; Li, XL; Xu, M; Yu, F; Yu, X | 1 |
| Chen, X; Guo, S; Jiao, W; Li, L; Li, R; Li, X; Liu, B; Luo, H; Su, C; Tang, J; Tian, Y; Wang, Q; Wang, W; Zhang, D | 1 |
2 other study(ies) available for glucagon and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Phosphoproteomics analysis of diabetic cardiomyopathy in aging-accelerated mice and effects of D-pinitol.
Topics: Aging; Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Disease Models, Animal; Glucagon; Heart; Inositol; Insulin; Mice; Myocardium; Phosphopeptides; Phosphorylation; Protein Interaction Maps; Proteomics; Signal Transduction | 2022 |
Si-Miao-Yong-An decoction preserves cardiac function and regulates GLC/AMPK/NF-κB and GLC/PPARα/PGC-1α pathways in diabetic mice.
Topics: AMP-Activated Protein Kinases; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Drugs, Chinese Herbal; Glucagon; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR alpha; Signal Transduction; Streptozocin | 2020 |